Alpha Dna Investment Management LLC Lemaitre Vascular Inc Transaction History
Alpha Dna Investment Management LLC
- $261 Million
- Q3 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 5,257 shares of LMAT stock, worth $484,274. This represents 0.19% of its overall portfolio holdings.
Number of Shares
5,257
Previous 6,069
13.38%
Holding current value
$484,274
Previous $499,000
2.2%
% of portfolio
0.19%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding LMAT
# of Institutions
291Shares Held
20.4MCall Options Held
5.2KPut Options Held
2.9K-
Black Rock Inc. New York, NY3.48MShares$320 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.98MShares$182 Million2.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$145 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.16MShares$107 Million1.93% of portfolio
-
Geneva Capital Management LLC878KShares$80.9 Million1.39% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $2.02B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...